Korea Joongang Daily
Korea JoongAng Daily

Medytox tightens its hold on the Middle East’s beauty boom

Korean biopharmaceutical company Medytox is expanding into the Middle East, a fast-growing pharmaceutical market often referred to as a "Pharmerging" — a blend of "pharmacy" and "emerging."

2025-02-17

Preliminary U.S. trade decision favors Hugel over Medytox in Botox-related case

Kosdaq-listed Hugel prevailed over Medytox in a preliminary decision by the U.S. International Trade Commission in a dispute over a Botox-related product.

2024-06-11

[NEWS ANALYSIS] Second Battle of the Botoxes breaks out in Korea

Botulinum toxin is at the center of another legal battle as Medytox accused Hugel of misappropriation of trade secrets.

2022-04-13

Medytox, Daewoong benefit as Botox deal nullifies ITC ban

After emerging victorious in a protracted trade secrets dispute last year, Medytox has received billions of dollars in license fees and royalty fees and bought a stake in the U.S. botulinum toxin maker Evolus, becoming its second largest stakeholder.

2021-02-22

Medytox to fight ministry's ban on Innotox in court

Medytox is set to initiate another legal battle against the Ministry of Food and Drug Safety, as the company announced Wednesday it will challenge a sales and production ban issued against its Innotox “Botox” product.

2020-12-23

U.S. ITC ends 'Botox brawl' in Medytox's favor, but reduces penalty

After a two-year investigation, the U.S. International Trade Commission has made a final determination in favor of Medytox in its high-profile “Botox brawl” with Daewoong Pharmaceutical.

2020-12-17

Medytox botches Botox labeling but cites wrinkle in law

The Ministry of Food and Drug Safety ordered Medytox to recall and destroy 50-unit, 100-unit, 150-unit and 200-unit dosages of Meditoxin, Medytox’s bestselling botulinum toxin, citing violations of the Pharmaceutical Affairs Act.

2020-10-20

ITC agrees to review its decision in Botox dispute

The Botox war between Medytox and Daewoong Pharmaceutical has taken an unexpected turn as the U.S. International Trade Commission (ITC) decided to partially review its initial determination in favor of Medytox.

2020-09-22

Medytox wins Botox face-off, but there's a wrinkle

The U.S. International Trade Commission (ITC) made an initial determination Monday. It concluded that Daewoong’s botulinum toxin product, Nabota, was made with bacteria and intellectual property stolen from Medytox.

2020-07-07

Medytox loses sales licenses for three most popular products

The Ministry of Food and Drug Safety removed Medytox's sales license for its main botulinum toxin, or Botox products on Thursday. They were responsible for 42.1 percent of Medytox’s sales revenue last year.

2020-06-18